Mark Christianson, Business Development Director at NeuroOne Medical Technologies, holds 293.99K shares in NeuroOne Medical Technologies (Ticker: NMTC).
What is the percentage of profitable transactions made by Mark Christianson?
The percentage of profitable transactions made by Mark Christianson is 86%.
What is the average return per transaction made by Mark Christianson?
The average return per transaction made by Mark Christianson is 24.80%.
What stocks does Mark Christianson hold?
Mark Christianson holds: NMTC stocks.
What was Mark Christianson’s latest transaction?
Mark Christianson latest transaction was an Uninformative Sell of $55.80.
What was Mark Christianson's most profitable transaction?
Mark Christianson’s most profitable transaction was an Informative Sell of NMTC stock on June 25, 2021. The return on the trade was 85.30%.
What is Mark Christianson's role in NeuroOne Medical Technologies?
Mark Christianson's role in NeuroOne Medical Technologies is Business Development Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.